Yunqing X. Yang
Zhengzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
In Situ Amplified Mutational mRNA Imaging Using a Spatially Confined CRISPR Nanoplatform.
Journal: Angewandte Chemie (International ed. in English)
Published: December 16, 2025
Molecular Subtypes and Risk Prediction Model Based on Malignant Cell Differentiation Trajectories in Breast Cancer.
Journal: Journal of cellular and molecular medicine
Published: November 27, 2024
A non-invasive preoperative model for predicting sentinel lymph node metastasis in breast cancer using clinical data and MRI.
Journal: BMC medical imaging
Published: November 24, 2024
Research Progresses and Applications of Knowledge Graph Embedding Technique in Chemistry.
Journal: Journal of chemical information and modeling
Published: September 20, 2024
METTL1-mediated tRNA m7G methylation and translational dysfunction restricts breast cancer tumorigenesis by fueling cell cycle blockade.
Journal: Journal of experimental & clinical cancer research : CR
Published: March 18, 2024
Retraction Note: Exosome-transmitted miR-567 reverses trastuzumab resistance by inhibiting ATG5 in breast cancer.
Journal: Cell death & disease
Published: November 10, 2023
Clinical analysis of 15 pregnant women complicated with moyamoya disease
Journal: Zhonghua fu chan ke za zhi
Published: April 18, 2023
Retraction Note to: Exosome-mediated lncRNA AFAP1-AS1 promotes trastuzumab resistance through binding with AUF1 and activating ERBB2 translation.
Journal: Molecular cancer
Published: July 12, 2022
Exosomal long noncoding RNA AGAP2-AS1 regulates trastuzumab resistance via inducing autophagy in breast cancer.
Journal: American journal of cancer research
Published: October 08, 2020
lncRNA ZNF649-AS1 Induces Trastuzumab Resistance by Promoting ATG5 Expression and Autophagy.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: December 15, 2019
Exosome-transmitted miR-567 reverses trastuzumab resistance by inhibiting ATG5 in breast cancer.
Journal: Cell death & disease
Published: October 30, 2019
Last Updated: 09/26/2026